Results 201 to 210 of about 715,867 (372)

Animal Naming Test Can Identify Covert Hepatic Encephalopathy in Patients With Cirrhosis With Limited Influence From Age or Educational Level

open access: yesHepatology Research, EarlyView.
Adjustments for age and educational level in animal naming test cause patients’ discomfort and limit its use in clinical practice. In our study, animal naming test was useful in identifying covert hepatic encephalopathy and its adjustment using age and educational level had limited incremental value the diagnostic ability.
Takao Miwa   +8 more
wiley   +1 more source

Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease [PDF]

open access: gold, 2023
Yuki Nakahata   +7 more
openalex   +1 more source

Impact of Early‐Line Systemic Therapies on Liver Function in Hepatocellular Carcinoma: Longitudinal Change of ALBI Score and Ammonia Level With and Without Anti‐VEGF Agents

open access: yesHepatology Research, EarlyView.
ABSTRACT Background and Aim Anti–vascular endothelial growth factor (VEGF) agents are widely used for hepatocellular carcinoma (HCC); inhibition of VEGF‐mediated liver regeneration may compromise hepatic reserve. We investigated the impact of anti‐VEGF therapy on liver function and risk factors for deterioration of albumin–bilirubin (ALBI) score during
Naoshi Nishida   +11 more
wiley   +1 more source

Medium chain triglycerides and hepatic encephalopathy [PDF]

open access: bronze, 1974
M. H. Morgan   +3 more
openalex   +1 more source

Hepatic Encephalopathy

open access: yesGastroenterology, 1979
A M, Hoyumpa   +4 more
openaire   +2 more sources

Guidance for Liver Rehabilitation in Chronic Liver Disease

open access: yesHepatology Research, EarlyView.
ABSTRACT In April 2023, the Japan Society of Hepatology published its official guidelines on liver rehabilitation for chronic liver disease. In this article, we summarize the current evidence on the role of liver rehabilitation in slowing the progression of chronic liver disease, particularly metabolic dysfunction‐associated steatotic liver disease ...
Shuji Terai   +26 more
wiley   +1 more source

PWE-153 Cost Effectiveness Of Rifaximin-a In The Reduction Of Recurrence Of Overt Hepatic Encephalopathy [PDF]

open access: bronze, 2014
CD Poole   +5 more
openalex   +1 more source

Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
Liver diseases are a major global health challenge, with current treatments inadequate. This review highlights the role of bacterial extracellular vesicles in liver inflammation, fibrosis, and metabolism. We also explore these from commensals and probiotics, their protective effects, and discuss research challenges and future therapeutic potential ...
Yakun Li   +3 more
wiley   +1 more source

P.16.8 ROLE OF TRANSCRANIAL DOPPLER (TCD) IN THE EVALUATION OF CEREBRAL HEMODYNAMIC IN CIRRHOTIC PATIENTS: CORRELATION WITH SEVERITY OF THE DISEASE AND MINIMAL HEPATIC ENCEPHALOPATHY (MHE) DEVELOPMENT

open access: bronze, 2014
Giuseppe Caracciolo   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy